Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Arkhiv Patologii|June 18, 2026
[HER2 status assessment in carcinomas of various localizations. A multicenter morphological study in the Russian Federation]L E Zavalishina, S V Vtorushin, G A Raskin, et al.
Biochemistry. Biokhimiia|January 28, 2014
Intratumor heterogeneity: nature and biological significanceT S Gerashchenko, E V Denisov, N V Litviakov, et al.
Kardiologiia|September 11, 2023
Clinical and Morphological Features of Myocardial Infarction in Patients With a New Coronavirus Infection COVID-19M V Zavyalova, A A Neklyudov, A V Zavyalov, et al.
Experimental Oncology|September 30, 2014
The phenomenon of multi-drug resistance in the treatment of malignant tumorsS V Vtorushin, K Y Khristenko, M V Zavyalova, et al.
Acta Naturae|May 3, 2017
Intratumoral Morphological Heterogeneity of Breast Cancer As an Indicator of the Metastatic Potential and Tumor ChemosensitivityT S Gerashchenko, M V Zavyalova, E V Denisov, et al.
Voprosy Onkologii|August 6, 2013
[Correlation of metastasis-free survival in patients with breast cancer and changes in the direction of expression of multidrug resistance genes during neoadjuvant chemotherapy]N V Litviakov, E Iu Garbukov, E M Slonimskaia, et al.
Acta Naturae|August 27, 2024
Evaluation of HER2/neu Expression in Metastatic Axillary Lymph Node Tissue of Breast Cancer Patients Using [99mTc]Tc-(HE)3-G3O D Bragina, L A Tashireva, D M Loos, et al.
Arkhiv Patologii|June 17, 2024
[Analysis of the work of the Immunohistochemical Quality Control Center of the Russian Medical Academy of Continuous Professional Education of the Ministry of Health of Russia in 2023]L E Zavalishina, A S Artemyeva, S V Vtorushin, et al.
Scientific Reports|December 5, 2022
Molecular subtype conversion in CTCs as indicator of treatment adequacy associated with metastasis-free survival in breast cancerE S Grigoryeva, L A Tashireva, V V Alifanov, et al.
Arkhiv Patologii|April 16, 2026
[Quality control of immunohistochemical studies in Russia in 2025: achievement and prospects]L E Zavalishina, S V Vtorushin, G A Raskin, et al.
Pageof 4